MMMM D, YYYY

Clinical Study Results Sanofi Pharma, including Sanofi Genzyme

Information about sponsored clinical trials and result information are provided for informational purposes only and are not intended to promote any product or use. Clinical study results are intended to report the results of the study that were known at the time of the study's completion. The results therefore do not provide a comprehensive and current review of the safety and efficacy of any drug based upon all information available. Physicians and patients should refer to the current approved product labeling for information on approved indications in their country.
This information is not intended to replace the advice of a health care professional. Only a physician can determine if a specific medicine is the correct or best treatment option for a particular patient. If you have questions, please consult a health care professional.

A - B - C - D - E - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

Clinical study results Sanofi pharma, including Sanofi Genzyme – Letter S

Generic Name Trade Name Condition Study Code Study Name ACCESS TO STUDY / PROTOCOL Access to results
SARILUMAB Kevzara Rheumatoid Arthritis ACT13480 SARILNIUSATURN EudraCT: 2012-004845-34
SARILUMAB Kevzara Rheumatoid Arthritis EFC13752 SARIL-RA-ONE EudraCT: 2013-002790-22
SARILUMAB Kevzara COVID-19 EFC16844 NA NCT04327388
SARILUMAB Not marketed Ankylosing Spondylitis DRI11073 ALIGN EudraCT: 2009-016068-35
SARILUMAB Kevzara Rheumatoid Arthritis EFC10832 SARIL-RA-TARGET EudraCT: 2011-003538-16
SARILUMAB Not marketed Ankylosing Spondylitis LTS11298 SUSTAIN EudraCT: 2010-019263-11
SARILUMAB Kevzara Rheumatoid Arthritis LTS13618 SARIL-RA-HARUKA NCT02373202
SARILUMAB Kevzara Rheumatoid Arthritis EFC11072 RA-MOBILITY EudraCT: 2009-016266-90
SARILUMAB Kevzara Rheumatoid Arthritis EFC14059 SARIL-RA-KAKEHASI NCT02293902
SARILUMAB Kevzara Rheumatoid Arthritis MSC12665 SARIL-RA-EASY EudraCT: 2012-004339-21
SARILUMAB Kevzara Rheumatoid Arthritis SFY13370 SARIL-RA-ASCERTAIN EudraCT: 2012-003536-23
SARILUMAB Kevzara Rheumatoid Arthritis EFC11574 RA-COMPARE EudraCT: 2012-001984-66
SARILUMAB Kevzara Rheumatoid Arthritis ACT11575 NA EudraCT: 2010-021020-94
SARILUMAB Kevzara Rheumatoid Arthritis SARILL08755 SariPRO NCT03449758
SEMULOPARIN Not Marketed Venous Thromboembolism DRI6243 TREK NCT00331838
SEMULOPARIN Not Marketed Venous Thromboembolism EFC10342 SAVE-HIP1 NCT00697099
SEMULOPARIN Not Marketed Venous Thromboembolism EFC10343 SAVE-HIP2 NCT00721760
SEMULOPARIN Not Marketed Venous Thromboembolism EFC10571 SAVE-KNEE NCT00718224
SEMULOPARIN Not Marketed Venous Thromboembolism EFC10572 SAVE-VEMED EudraCT: 2008-000228-13
SEMULOPARIN Not Marketed Venous Thromboembolism EFC10636 SAVE-HIP3 NCT00709904
SEMULOPARIN Not Marketed Venous Thromboembolism EFC6520 SAVE-ABDO EudraCT: 2007-007942-36
SEMULOPARIN Not Marketed Venous Thromboembolism EFC6521 SAVE-ONCO NCT00694382
SEMULOPARIN Not Marketed Venous Thromboembolism PKM11204 NA NCT01567904
SENNA + CASSIA Naturetti (Cassia Fistula + Senna Alexandrina Miller) Constipation SENCA_L_04392 NA NCT00931853
SENNA + CASSIA Naturetti (Cassia Fistula + Senna Alexandrina Miller) Constipation SENCA_L_04746 NA NCT00994851
SEVELAMER CARBONATE Renvela Chronic Kidney Disease DRI12793 NA NCT01574326
SEVELAMER CARBONATE Renvela Chronic Kidney Disease GD3-163-201* NA NCT00440648
SEVELAMER CARBONATE Renvela Chronic Kidney Disease GD3-199-301* NA NCT00268957
SEVELAMER CARBONATE Renvela Chronic Kidney Disease SVCARB00105 NA EUdraCT: 2005-003233-41
SEVELAMER CARBONATE Renvela Chronic Kidney Disease SVCARB07609 NA NCT01574326
SEVELAMER CARBONATE Renvela Chronic Kidney Disease SVCARB10012 TOSCANA NCT02332811
SEVELAMER CARBONATE Renvela Chronic Kidney Disease APB00108 LEAP NCT00853242
SEVELAMER CARBONATE Renvela Hyperphosphatemia EFC14011 RECOVER NCT03001011
SEVELAMER HYDROCHLORIDE Renagel Healthy Volunteers GTC-02-101* NA
SEVELAMER HYDROCHLORIDE Renagel Chronic Kidney Disease GTC-10-201* NA
SEVELAMER HYDROCHLORIDE Renagel Chronic Kidney Disease GTC-10-202* NA
SEVELAMER HYDROCHLORIDE Renagel Healthy Volunteers GTC-10-801* NA
SEVELAMER HYDROCHLORIDE Renagel Chronic Kidney Disease GTC-36-203* NA
SEVELAMER HYDROCHLORIDE Renagel Chronic Kidney Disease GTC-36-301* NA
SEVELAMER HYDROCHLORIDE Renagel Chronic Kidney Disease GTC-36-302* NA
SEVELAMER HYDROCHLORIDE Renagel Chronic Kidney Disease GTC-45-204* NA
SEVELAMER HYDROCHLORIDE Renagel Chronic Kidney Disease GTC-45-206* NA
SEVELAMER HYDROCHLORIDE Renagel Healthy Volunteers GTC-45-803* NA
SEVELAMER HYDROCHLORIDE Renagel Healthy Volunteers GTC-45-804* NA
SEVELAMER HYDROCHLORIDE Renagel Healthy Volunteers GTC-45-807* NA
SEVELAMER HYDROCHLORIDE Renagel Healthy Volunteers GTC-45-808* NA
SEVELAMER HYDROCHLORIDE Renagel Chronic Kidney Disease GTC-45-901* NA
SEVELAMER HYDROCHLORIDE Renagel Chronic Kidney Disease GTC-49-301* NA
SEVELAMER HYDROCHLORIDE Renagel Chronic Kidney Disease GTC-68-208* NA
SEVELAMER HYDROCHLORIDE Renagel Chronic Kidney Disease GTC-68-209 NA NCT00324376
SEVELAMER HYDROCHLORIDE Renagel Healthy Volunteers ICR013769* NA
SEVELAMER HYDROCHLORIDE Renagel Healthy Volunteers ICR013821* NA
SEVELAMER HYDROCHLORIDE Renagel Chronic Kidney Disease REN-001-00* NA
SEVELAMER HYDROCHLORIDE Renagel Chronic Kidney Disease REN-002-01* NA
SODIUM HYALURONATE Hyalgan Arthritis L_8229 HUPS NCT00377624
SODIUM HYALURONATE Hyalgan Arthritis L_9385 TREAD-20 NCT00130468
SODIUM HYALURONATE Hyalgan Arthritis L_9385EXT TREAD-20 NCT00830830
SOMATROPIN Maxomat Fetal Growth Retardation FH5126A NA NCT00452491
SOMATROPIN Maxomat Growth Hormone Deficiency L_8912 NA NCT00476385
SOMATROPIN Maxomat Growth Hormone Deficiency MAX08 NOONAN'S NCT00452725
STABLE GLUCAGON Not marketed Diabetes Mellitus, Type 1 TDU14518 NA NCT02625636


References:
*These study results were previously posted on GenzymeClinicalResearch.com
**This link replaces the same summary that was previously posted